Key result
BMI <30, age 75-80, and lipid-lowering drugs predict 31-60 day HF rehospitalization in older women.
Why the study?
The study sought to identify social, hemodynamic, and comorbid risk factors associated with 31- to 60-day heart failure rehospitalization in older African American and Caucasian women.
What are the social, hemodynamic, and comorbid risk factors associated with 31- to 60-day heart failure rehospitalization in older women?
Case-Control (n=188)
No
What are the social, hemodynamic, and comorbid risk factors associated with 31- to 60-day heart failure rehospitalization in older women?
p-value: p=0.12
In older women with heart failure, specific age brackets, lower BMI categories, and lipid-lowering therapy use were identified as predictors for 31- to 60-day rehospitalization.
May warrant targeted post-discharge monitoring in older women; hypothesis-generating and requires prospective validation before practice change.
The current study sought to identify social, hemodynamic, and comorbid risk factors associated with 31-to 60-day heart failure (HF) rehospitalization in African American and Caucasian older (aged >65 years) women. A non-equivalent, case-control, quantitative design study using secondary data analysis of medical records from a local community hospital in the Southeast region of the United States was performed over a 3-year period. Relationships between predictor variables and the outcome variable, 31- to 60-day HF rehospitalization, were explored. The full model containing all predictors was not able to distinguish between predictors (χ 2 [21, N = 188] = 35.77, p = 0.12). However, a condensed model showed that body mass index (BMI) level 1 (<25 kg/m 2 ), BMI level 2 (>25 and <30 kg/m 2 ), age 75 to 80 years, and those taking lipid-lowering agents were significant predictors. Subtype of HF (reduced or preserved) and race did not predict HF rehospitalization within the specified time period. Multiple comorbid risk factors failed to consistently predict rehospitalization, which may reflect dated HF-specific approaches and therapies. Future studies should evaluate contributions of current targeted post-discharge methods or therapies. [ Research in Gerontological Nursing, 15 (4), 179–191.]
No takes yet. Share an insight, caveat, or question.
Sue-Ling et al. (2022) conducted a case-control in Heart failure (n=188). Social, hemodynamic, and comorbid risk factors was evaluated on 31- to 60-day heart failure rehospitalization (p=0.12). BMI <30 kg/m2, age 75 to 80 years, and lipid-lowering agent use were significant predictors of 31- to 60-day heart failure rehospitalization in older women, while race and HF subtype were not.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: